Standard Biotools (LAB) Change in Intangibles (2011 - 2015)

Standard Biotools (LAB) reported Change in Intangibles of $6.5 million for Q4 2015, up 12900.0% quarter-over-quarter from $50000.0 in Q3 2015.

Standard Biotools (LAB) Change in Intangibles (2011 - 2015) Analysis & Trends

Standard Biotools (LAB) has 3 years of Change in Intangibles data on file, last reported at $6.5 million in Q4 2015.

  • Change in Intangibles for Q4 2015 came in at $6.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $6.5 million (up 3723.53% YoY), and the FY2017 annual result was $50000.0, changed N/A from the prior year.
  • Change in Intangibles climbed to $6.5 million in Q4 2015 per LAB's latest filing, from $50000.0 in the prior quarter.
  • Over five years, Change in Intangibles peaked at $6.5 million in Q4 2015 and troughed at -$2.0 million in Q4 2011.
  • A 3-year average of $793666.7 and a median of $85000.0 in 2015 frame the typical range for Change in Intangibles.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -31.61 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Standard Biotools 319.06 Mn -136.11 Mn 11.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 6.50 Mn
Dec 31, 2015 6.50 Mn
Sep 30, 2015 50,000.00
Sep 30, 2015 50,000.00
Mar 31, 2015 120,000.00
Mar 31, 2015 120,000.00
Dec 31, 2013 197,000.00
Dec 31, 2013 197,000.00
Sep 30, 2013 -105,000.00
Sep 30, 2013 -105,000.00
Dec 31, 2011 -2.00 Mn
Dec 31, 2011 -2.00 Mn